| Methylprednisolone Sodium Succinate in Treating Patients With Acute Graft-versus-Host Disease of the Gastrointestinal Tract (NCT02425813) | Wake Forest University Health Sciences | 2015-10-01 |
| Penile Intracavernosal Stem Cells Therapy for Erectile Dysfunction (NCT02665520) | Elaj medical centers | 2015-10-01 |
| Safety and Dose Ranging Study of Human Insulin Receptor MAb-IDUA Fusion Protein in Adults and Children With MPS I (NCT03053089) | ArmaGen, Inc | 2015-10-01 |
| Systemic Chemotherapy Versus Transcatheter Arterial Chemoembolization(TACE) for Hepatocellular Carcinoma (NCT02585479) | Guangxi Medical University | 2015-10-01 |
| Impact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controlled-trial. (NCT03296553) | National Institute of Cancerología | 2015-10-01 |
| Dose Escalation of OXi4503 as Single Agent and Combination With Cytarabine w/Subsequent Ph 2 Cohorts for AML and MDS (NCT02576301) | Mateon Therapeutics | 2015-10-01 |
| Trial of Paclitaxel Plus Gemcitabine and Cisplatin in Bladder Cancer (NCT02560038) | The University of Texas Health Science Center, Houston | 2015-10-01 |
| Prevention of Colic With the Probiotic Lactobacillus Reuteri (NCT02577133) | Hospital General Naval de Alta Especialidad - Escuela Medico Naval | 2015-10-01 |
| Phase IIA Open Label Study to Evaluate Efficacy and Safety of BL-8040 Followed by (hATG), Cyclosporine and Methyprednisolone in Adult Subjects With Aplastic Anemia or Hypoplastic Myelodysplastic Syndrome (NCT02462252) | BioLineRx, Ltd. | 2015-10-01 |
| NP202 for Treatment of Post -STEMI Left Ventricular Systolic Dysfunction (NCT02557217) | Armaron Bio Pty Ltd | 2015-10-01 |
| Adjuvant Transcatheter Arterial Chemoembolization Versus Adjuvant Systemic Chemotherapy for Hepatocellular Carcinoma (NCT02584556) | Guangxi Medical University | 2015-10-01 |
| FAST Fish Phase IIb Clinical Trial for the Treatment of Fish Allergy by Subcutaneous Immunotherapy (NCT02382718) | George Stavroulakis | 2015-10-01 |
| HL2351 CAPS Phase II Study (NCT02853084) | Handok Inc. | 2015-10-01 |
| Phase 2 Study of Gemcitabine and Docetaxel Combination Chemotherapy in Patients With Carcinoma of Unknown Primary (NCT02590055) | Samsung Medical Center | 2015-10-01 |
| The Effect of Folinic Acid Rescue Following MTX GVHD Prophylaxis on Regimen Related Toxicity and Transplantation Outcome (NCT02506231) | Rabin Medical Center | 2015-10-01 |
| Minimally Invasive Transthoracic Device Closure in Perimembranous Ventricular Septal Defect (NCT02644330) | Chinese Academy of Medical Sciences, Fuwai Hospital | 2015-10-01 |
| Novel Treatment Option for Neuropathic Pain (NCT02490436) | Sorlandet Hospital HF | 2015-10-01 |
| Safety & Efficacy of Pegolsihematide for Treatment of Anemia in Participants on Dialysis (NCT02586402) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2015-10-01 |
| Radium 223 Following Intermittent ADT (NCT02656563) | Canadian Urology Research Consortium | 2015-10-01 |
| Metformin for Reduction of Paclitaxel-Related Neuropathy in Patients With Breast Cancer (NCT02360059) | M.D. Anderson Cancer Center | 2015-10-01 |
| The Ruxo-BEAT Trial in Patients With High-risk Polycythemia Vera or High-risk Essential Thrombocythemia (NCT02577926) | RWTH Aachen University | 2015-10-01 |
| Study to Assess the Safety, Tolerability, PK and PD Response of PE0139 Injection in Adult Subjects With T2DM (NCT02581657) | PhaseBio Pharmaceuticals Inc. | 2015-10-01 |
| Nabilone in Cannabis Users With PTSD (NCT03251326) | New York State Psychiatric Institute | 2015-10-01 |
| intrathecaم Ketamine, Morphine and Both for Lower Abdominal Cancer Surgery Pain (NCT02726828) | Assiut University | 2015-10-01 |
| Evaluate the Safety, Tolerability, Immunogenicity and Efficacy of UB-311 in Mild Alzheimer's Disease (AD) Patients (NCT02551809) | United Neuroscience Ltd. | 2015-10-01 |
| Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy (NCT02314156) | Northwestern University | 2015-10-01 |
| Enterotoxigenic Escherichia Coli (ETEC) ETVAX Vaccine Trial in Bangladesh (NCT02531802) | PATH | 2015-10-01 |
| Belatacept Conversion in Proteinuric Kidney Transplant Recipients (NCT02327403) | Brigham and Women's Hospital | 2015-10-01 |
| Abatacept for SLE Arthritis (IM101-330) (NCT02429934) | University of California, Los Angeles | 2015-10-01 |
| Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies With Alpha Beta TCell and B Cell Depletion Using the CliniMACS Device (NCT02600208) | Julie-An M. Talano | 2015-10-01 |
| IVF in Pediatric Concussion (NCT02214316) | Washington University School of Medicine | 2015-10-01 |
| Effects of Sildenafil on CFTR-dependent Ion Transport Activity (NCT01132482) | National Jewish Health | 2015-10-01 |
| Autologous Immunoregulatory Dendritic Cells for Type 1 Diabetes Therapy (NCT02354911) | DiaVacs, Inc. | 2015-10-01 |
| Subcutaneous Immunotherapy for Mouse in Adults (NCT02532179) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-10-01 |
| Study of URC102 to Assess the Safety and Efficacy in Gout Patients (NCT02557126) | JW Pharmaceutical | 2015-10-01 |
| An Efficacy/Safety Study of Perampanel for Reducing Essential Tremor (NCT02668146) | VA Greater Los Angeles Healthcare System | 2015-10-01 |
| Prevention of Levodopa-induced Dyskinesias by Transcranial Static Magnetic Field Stimulation (tSMS) (NCT02657681) | Fundación de investigación HM | 2015-10-01 |
| Role of Sympathetic Overactivity and Angiotensin II in PTSD and CV (NCT02560805) | Emory University | 2015-10-01 |
| Mannitol Cream for Post Herpetic Neuralgia (NCT02484170) | University of British Columbia | 2015-09-30 |
| Pacritinib for Patients With Lower-Risk Myelodysplastic Syndromes (MDS) (NCT02469415) | M.D. Anderson Cancer Center | 2015-09-30 |
| Phase 1/2 Study of the Safety and Efficacy of Rociletinib in Combination With Trametinib in Patients With mEGFR-positive Advanced or Metastatic Non-small Cell Lung Cancer (NCT02580708) | Clovis Oncology, Inc. | 2015-09-30 |
| A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors (NCT02576431) | Bayer | 2015-09-30 |
| suPERficial Slow-flow Vascular malFORMations Treated With sirolimUS (NCT02509468) | University Hospital, Tours | 2015-09-30 |
| A Study to Investigate the Effect of 7-Keto on Resting Metabolic Rate in Overweight Adults (NCT04782024) | KGK Science Inc. | 2015-09-30 |
| A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD) (NCT02546700) | Hoffmann-La Roche | 2015-09-30 |
| Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With RRMS (NCT02410200) | Biogen | 2015-09-30 |
| Endocrine Response in Women With Invasive Lobular Breast Cancer (NCT02206984) | Priscilla McAuliffe | 2015-09-30 |
| Safety,Tolerability,Pharmacokinetics and Efficacy of CFZ533 in Moderate to Severe Myasthenia Gravis (NCT02565576) | Novartis Pharmaceuticals | 2015-09-29 |
| Study to Evaluate Efficacy & Safety of Tralokinumab in Subjects With Asthma Inadequately Controlled on Corticosteroids (NCT02449473) | AstraZeneca | 2015-09-29 |
| Safety, Tolerability, Pharmacokinetics, and Efficacy of JBT-101 (Lenabasum) in Cystic Fibrosis (NCT02465450) | Corbus Pharmaceuticals Inc. | 2015-09-29 |
| A Study to Evaluate the Efficacy of MEDI7510 in Older Adults (NCT02508194) | MedImmune LLC | 2015-09-29 |
| CLINICAL PROTOCOL to Investigate the Long-term Safety and Efficacy of Metreleptin in Various Forms of Partial Lipodystrophy (NCT02654977) | University of Michigan | 2015-09-29 |
| Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas (NCT02523014) | Alliance for Clinical Trials in Oncology | 2015-09-28 |
| Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injections for Post-Operative Pain Following Colorectal Surgery (NCT02489526) | Vivozon, Inc. | 2015-09-28 |
| Study of the Efficacy and Safety of the Ranibizumab Port Delivery System for Sustained Delivery of Ranibizumab in Patients With Subfoveal Neovascular Age-Related Macular Degeneration (NCT02510794) | Genentech, Inc. | 2015-09-28 |
| Gene Therapy Study in Severe Haemophilia A Patients (270-201) (NCT02576795) | BioMarin Pharmaceutical | 2015-09-28 |
| Proof-of-Concept Study With BT063 in Subjects With Systemic Lupus Erythematosus (NCT02554019) | Biotest | 2015-09-28 |
| Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease (NCT02503501) | HealthPartners Institute | 2015-09-28 |
| Phase I/II Trial of Alectinib and Bevacizumab in Patients With Advanced, Anaplastic Lymphoma Kinase (ALK)-Positive, Non-Small Cell Lung Cancer (NCT02521051) | Massachusetts General Hospital | 2015-09-28 |
| Gingival Crevicular Fluid Levels of Protein Carbonyl Following the Use of Lycopene in Chronic Periodontitis (NCT03203746) | Maie Sami tawfik | 2015-09-28 |
| Combination Chemotherapy & Lenalidomide in Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma (NCT02561273) | University of Nebraska | 2015-09-28 |
| CLG561 Proof-of-Concept Study as a Monotherapy and in Combination With LFG316 in Subjects With Geographic Atrophy (GA) (NCT02515942) | Alcon Research | 2015-09-25 |
| Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome (NCT02468193) | Novartis Pharmaceuticals | 2015-09-24 |
| QUILT-3.009: Patients With Stage III (IIIB) or Stage (IV) Merkel Cell Carcinoma (MCC) (NCT02465957) | ImmunityBio, Inc. | 2015-09-24 |
| Study of Pegcetacoplan (APL-2) Therapy in Patients With Geographic Atrophy (NCT02503332) | Apellis Pharmaceuticals, Inc. | 2015-09-24 |
| Study of Lifileucel (LN-144), Autologous Tumor Infiltrating Lymphocytes, in the Treatment of Patients With Metastatic Melanoma (NCT02360579) | Iovance Biotherapeutics, Inc. | 2015-09-24 |
| Androgen Deprivation Therapy in Advanced Salivary Gland Cancer (NCT01969578) | European Organisation for Research and Treatment of Cancer - EORTC | 2015-09-24 |
| Prostate Artery Embolization as a Treatment for Benign Prostatic Hyperplasia in Men With Prostates Larger Than 90 Grams (NCT02396420) | South Florida Medical Imaging, PA | 2015-09-24 |
| A Study Evaluating if Pridopidine is Safe, Efficacious, and Tolerable in Patients With Huntington's Disease (NCT02494778) | Prilenia | 2015-09-24 |
| Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation (NCT02356159) | National Cancer Institute (NCI) | 2015-09-24 |
| Evaluation of Safety, Pharmacokinetics and Efficacy of Ceftazidime and Avibactam (CAZ-AVI ) Compared With Cefepime in Children From 3 Months to Less Than 18 Years of Age With Complicated Urinary Tract Infections (cUTIs) (NCT02497781) | Pfizer | 2015-09-24 |
| Rechallenge of Cetuximab Combined With Irinotecan as Third-line Chemotherapy in Patients With Metastatic Colorectal Cancer - Phase II Study (NCT02316496) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2015-09-23 |
| Phase IIb Study of IFN-K in Systemic Lupus Erythematosus (NCT02665364) | Neovacs | 2015-09-23 |
| Compare Efficacy of CHOP Versus Fractionated ICED in Transplant-eligible Patients With Previously Untreated PTCL (NCT02445404) | Samsung Medical Center | 2015-09-23 |
| A Safety Study of Oraxol (HM30181 + Oral Paclitaxel) in Cancer Patients (NCT04180384) | Athenex, Inc. | 2015-09-23 |
| Sporadic Angiomyolipomas (AMLs) Growth Kinetics While on Everolimus (NCT02539459) | Fox Chase Cancer Center | 2015-09-23 |
| Alemtuzumab or Tocilizumab in Combination With Etoposide and Dexamethasone for the Treatment of Adult Patients With Hemophagocytic Lymphohistiocytosis (NCT02385110) | M.D. Anderson Cancer Center | 2015-09-23 |
| Open Label Phase Two Study of Enzalutamide With Concurrent Administration of Radium Ra 223 Dichloride in Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Symptomatic Bone Metastasis (NCT02507570) | Carolina Research Professionals, LLC | 2015-09-23 |
| Can Vitamin D3 Improve Cognitive Function in Individuals With Type 2 Diabetes? (THINK-D) (NCT02416193) | Loyola University | 2015-09-23 |
| Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer (NCT02397083) | M.D. Anderson Cancer Center | 2015-09-23 |
| Pilot Study of Niacinamide in Polycystic Kidney Disease (NIAC-PKD2) (NCT02558595) | University of Kansas Medical Center | 2015-09-22 |
| PRednisone Plus EVerolimus in Patients With Metastatic Renal Cell Cancer After Failure of VEGFR -TKI (NCT02479490) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2015-09-22 |
| Pacritinib to Inhibit JAK/STAT Signaling in Refractory Colorectal Cancer (NCT02277093) | Washington University School of Medicine | 2015-09-22 |
| Trial to Investigate the Effect of ESN364 in Early Postmenopausal Women Suffering From Hot Flashes (NCT05419908) | Ogeda S.A. | 2015-09-21 |
| A Study to Evaluate the Effect of Dapagliflozin With and Without Saxagliptin on Albuminuria, and to Investigate the Effect of Dapagliflozin and Saxagliptin on HbA1c in Patients With Type 2 Diabetes and CKD (NCT02547935) | AstraZeneca | 2015-09-21 |
| Stereotactic Radiotherapy Combined With Chemotherapy or Not for Treatment of Oligometastases in HNSCC (NCT03070366) | Groupe Oncologie Radiotherapie Tete et Cou | 2015-09-21 |
| Study on the Role of Brentuximab Vedotin as Single Agent in the Treatment of Relapsed/Refractory CD30+ PTCL Patients (NCT02497131) | Fondazione Italiana Linfomi - ETS | 2015-09-21 |
| Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 Diabetes (NCT02461589) | Novo Nordisk A/S | 2015-09-21 |
| 68Ga-RM2 for PET/CT of Gastrin Releasing Peptide Receptor (GRPr) Expression in Prostate Cancer (NCT02559115) | Memorial Sloan Kettering Cancer Center | 2015-09-21 |
| Micafungin Prophylaxis During 1st Induction Chemotherapy for De Novo Acute Leukemia (NCT02440178) | Seoul National University Hospital | 2015-09-19 |
| An Open-label Extension Study of an Investigational Drug, Fitusiran, in Patients With Moderate or Severe Hemophilia A or B (NCT02554773) | Genzyme, a Sanofi Company | 2015-09-18 |
| A Study of Metronomic CP and JX-594 in Patients With Advanced Breast Cancer and Advanced Soft-tissue Sarcoma (METROmaJX) (NCT02630368) | Institut Bergonié | 2015-09-18 |
| Russia/Ukraine Suppression of Ovarian Activity Study (NCT02550977) | Bayer | 2015-09-18 |
| Pembrolizumab and Stereotactic Body Radiation Therapy or Non-Stereotactic Wide-Field Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer (NCT02444741) | M.D. Anderson Cancer Center | 2015-09-17 |
| A Trial Evaluating Maintenance Therapy With Lamivudine (Epivir®) and Dolutegravir (Tivicay®) in Human Immunodeficiency Virus 1 (HIV-1) Infected Patients Virologically Suppressed With Triple Highly Active Antiretroviral Therapy (HAART) (ANRS 167 Lamidol) (NCT02527096) | ANRS, Emerging Infectious Diseases | 2015-09-17 |
| A Safety, Tolerability, Efficacy and Exposure Study of XEN801 Topical Gel (NCT02656043) | Xenon Pharmaceuticals Inc. | 2015-09-17 |
| Afatinib in NSCLC With HER2 Mutation (NCT02369484) | ETOP IBCSG Partners Foundation | 2015-09-16 |
| A Long Term Extension Trial of BI 655066/ABBV-066 (Risankizumab), in Patients With Moderately to Severely Active Crohn's Disease (NCT02513459) | AbbVie | 2015-09-16 |
| A Phase I/II Safety, Tolerability, Immunogenicity, and Bioactivity Study of DE-122 Injectable Solution for Refractory Exudative Age-related Macular Degeneration (NCT02555306) | Santen Inc. | 2015-09-16 |
| Evaluating the Safety and Effectiveness of Interferon-Free Treatment of Hepatitis C Virus Infection in HIV-Coinfected Adults on Antiretroviral Therapy (NCT02194998) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-09-16 |